Skip to content

Arrhythmogenic Right Ventricular Cardiomyopathy 15 C5830135

Published: July 22, 2026Updated: August 25, 2026

A specific genetic subtype of arrhythmogenic cardiomyopathy. The heart muscle progressively weakens due to genetic changes affecting cell connections. Management focuses on preventing arrhythmias, regular monitoring, and avoiding competitive sports.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
I78.0
ICD-11
BA00.0
Body system
cardiovascular
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Ventricular arrhythmias

!

Syncope

Chest discomfort or palpitations

(cardiovascular)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Exercise intolerance

(cardiovascular)

Right ventricular dilatation

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease management and monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

ICD Implantation

Implantable cardioverter-defibrillator provides continuous monitoring and termination of life-threatening ventricular arrhythmias through programmed shock delivery. Standard preventive strategy for high-risk ARVC patients.

surgical
3

Beta-Blocker Therapy

Beta-blockers reduce cardiac adrenergic stimulation, decreasing the frequency and severity of ventricular arrhythmias. Titration begins at low doses with gradual increases based on tolerability.

medication

Additional treatment options

Ventricular Tachycardia Ablation

Endocardial and/or epicardial catheter ablation targets arrhythmogenic substrate within the right ventricular tissue. Advanced mapping techniques guide precise lesion delivery.

procedure

Genetic Counseling and Family Screening

Comprehensive genetic evaluation identifies affected family members and informs reproductive decisions. Psychological support addresses anxiety related to inherited cardiac conditions and ICD concerns.

psychological

Competitive Sports Exclusion

Avoidance of vigorous competitive athletics and high-intensity endurance exercise significantly reduces arrhythmia burden and may slow disease progression in ARVC patients.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Arrhythmogenic Right Ventricular Cardiomyopathy 15 C5830135?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Corrado D, Link MS, Calkins H. 2020 International Consensus on Arrhythmogenic Right Ventricular Cardiomyopathy. Heart Rhythm. 2020;17(11):1821-1845.

guideline2020
2

Basso C, Corrado D, Marcus FI. Arrhythmogenic right ventricular cardiomyopathy. Lancet. 2019;393(10172):742-755.

review2019
3

Cadrin-Tourigny J, Bosman LP, Tadros R. Long-term arrhythmic outcomes in arrhythmogenic right ventricular cardiomyopathy. JACC Clin Electrophysiol. 2023;9(2):198-210.

clinical_trial2023
4

Gandjbakhch E, Redheuil A, Pousset F. Diagnosis and prognosis of arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis. Europace. 2021;23(7):1091-1099.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Arrhythmogenic Right Ventricular Cardiomyopathy 15 C5830135. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy